MedTrace Logo

Development of a New Device and Method to Assess the Degree of Myopia and/or Astigmatism in Myopic People

NCT07297810 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-12-22

No results posted yet for this study

Summary

The purpose of this clinical investigation is to check whether the new device can correctly measure a person's degree of myopia and astigmatism.

To evaluate and improve the device's performance, the results (optical correction values and the associated visual acuity) obtained with the investigational device will be compared with the results obtained using standard instruments commonly used by eye care professionals.

Conditions

  • Myopia

Interventions

DEVICE

Optical correction values obtained with investigational device and visual acuity

Participants optical correction values are determined using the investigational device and their visual acuity is measured with this optical correction

DEVICE

Optical correction values obtained with an autorefractometer and visual acuity

Participants optical correction values are determined using an autorefractometer (objective refraction) and their visual acuity is measured with this optical correction

DEVICE

Optical correction values obtained with a phoropter and visual acuity

Participants optical correction values are determined using a phoropter (subjective refraction) and their visual acuity is measured with this optical correction

Sponsors & Collaborators

  • Essilor International

    lead INDUSTRY

Principal Investigators

  • Gildas Marin, PhD · Essilor International

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2027-06-30
Completion
2027-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07297810 on ClinicalTrials.gov